VSPharmTech Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Series B
- Investors
-
14
VSPharmTech General Information
Description
Developer of radiation sensitizer drugs designed to increase the efficacy of anticancer drugs. The company specializes in technology commercialization developed by domestic and overseas anticancer research groups and in mechanism-driven, synergy-equipped radiosensitizers that excel in low toxicity, enabling patients and the healthcare sector to undergo chemotherapy with safe and effective drugs and to offer safe treatment.
Contact Information
Website
www.vspharmtech.comCorporate Office
- Room 410, 191, Seongseo4chacheomdan-ro
- Dalseo-gu, Woram-dong
- Daegu, Shincheon 41256
- South Korea
Corporate Office
- Room 410, 191, Seongseo4chacheomdan-ro
- Dalseo-gu, Woram-dong
- Daegu, Shincheon 41256
- South Korea
VSPharmTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series B) | 17-Sep-2025 | Completed | Clinical Trials - Phase 2 | |||
| 11. Accelerator/Incubator | 21-May-2024 | Completed | Clinical Trials - Phase 2 | |||
| 10. Accelerator/Incubator | 23-Oct-2023 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC (Series B) | 19-Jun-2023 | Completed | Clinical Trials - Phase 2 | |||
| 8. Early Stage VC (Series A) | 01-Mar-2022 | Completed | Clinical Trials - General | |||
| 7. Early Stage VC | 01-Dec-2021 | Completed | Clinical Trials - General | |||
| 6. Seed Round | 01-May-2020 | Completed | Startup | |||
| 5. Accelerator/Incubator | 31-Aug-2019 | Completed | Startup | |||
| 4. Seed Round | 01-Mar-2019 | $311K | $311K | Completed | Startup | |
| 3. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
VSPharmTech Patents
VSPharmTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026220309-A1 | Head and neck cancer treatment | Pending | 14-Apr-2025 | ||
| WO-2026176390-A1 | Methods and compositions for enhancing radiation therapy with dopamine receptor (drd2)‑binding compounds | Pending | 20-Feb-2025 | ||
| US-20250268892-A1 | Treatment of cancer using aripiprazole and anticancer agent | Pending | 27-Feb-2024 | ||
| US-20260263453-A1 | Treatment of cancer using aripiprazole and anticancer agent | Pending | 27-Feb-2024 | ||
| WO-2025181652-A1 | Treatment of cancer using aripiprazole and anticancer agent | Pending | 27-Feb-2024 | A61K31/555 |
VSPharmTech Signals
VSPharmTech Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JCH Investment | Venture Capital | Minority | ||
| Seoul Biohub | Accelerator/Incubator | |||
| BiiG WAVE | Accelerator/Incubator | |||
| Korea Venture Investment | Fund of Funds | Minority | ||
| Samho Green Investment | Venture Capital | Minority |
VSPharmTech FAQs
-
When was VSPharmTech founded?
VSPharmTech was founded in 2018.
-
Where is VSPharmTech headquartered?
VSPharmTech is headquartered in Daegu, South Korea.
-
What is the size of VSPharmTech?
VSPharmTech has 17 total employees.
-
What industry is VSPharmTech in?
VSPharmTech’s primary industry is Drug Discovery.
-
Is VSPharmTech a private or public company?
VSPharmTech is a Private company.
-
What is VSPharmTech’s current revenue?
The current revenue for VSPharmTech is .
-
How much funding has VSPharmTech raised over time?
VSPharmTech has raised $6.81M.
-
Who are VSPharmTech’s investors?
JCH Investment, Seoul Biohub, BiiG WAVE, Korea Venture Investment, and Samho Green Investment are 5 of 14 investors who have invested in VSPharmTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process